MODIFICATION TO: MEDRAD SPECTRIS SOLARIS MR INJECTOR SYSTEM

Injector And Syringe, Angiographic

MEDRAD, INC.

The following data is part of a premarket notification filed by Medrad, Inc. with the FDA for Modification To: Medrad Spectris Solaris Mr Injector System.

Pre-market Notification Details

Device IDK012950
510k NumberK012950
Device Name:MODIFICATION TO: MEDRAD SPECTRIS SOLARIS MR INJECTOR SYSTEM
ClassificationInjector And Syringe, Angiographic
Applicant MEDRAD, INC. ONE MEDRAD DR. Indianola,  PA  15051
ContactLorraine R Fredes
CorrespondentLorraine R Fredes
MEDRAD, INC. ONE MEDRAD DR. Indianola,  PA  15051
Product CodeDXT  
CFR Regulation Number870.1650 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2001-09-04
Decision Date2001-10-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.